108791 ⎘
Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor; Animal cells or tissues; Human cells or tissues; Vertebrate cells; Cells of skeletal and connective tissues; Mesenchyme Smooth muscle cells
METHODS AND SYSTEMS FOR CONVERTING PRECURSOR CELLS INTO INTESTINAL TISSUES THROUGH DIRECTED DIFFERENTIATION
#2ENGINEERED HUMAN CARDIAC TISSUE
#3BIOENGINEERED INTERNAL ANAL SPHINCTER CONSTRUCTS AND METHODS OF USE THEREOF
#4METHODS TO FABRICATE LIVING CELL VESSELS OF NON-UNIFORM AND SPATIALLY HETEROGENOUS ARCHITECTURE
#5A Human Pluripotent Stem Cell-Based Screening For Smooth Muscle Cell Differentiation and Disease
#6METHODS OF PRODUCING MULTI-LAYERED TUBULAR TISSUE CONSTRUCTS
#7METHODS FOR OBTAINING INDUCED SMOOTH MUSCLE CELLS
#8COMPOSITIONS AND METHODS FOR PRODUCING SMOOTH MUSCLE CELLS
#9Generating Vasculogenic Cell Populations
#10Compositions And Methods For Making And Using Atherosclerotic Nanomatrix Vascular Sheets
#11HUMAN IPSC-DERIVED VASCULAR-RELATED AND HEMATOPOETIC CELLS FOR THERAPIES AND TOXICOLOGY/DRUG SCREENINGS
#12GENERATING CARDIAC PROGENITOR CELLS FROM PLURIPOTENT STEM CELLS USING ISOXAZOLE OR ISOXAZOLE LIKE COMPOUNDS
#13CELL CULTURE COMPOSITION COMPRISING CHLORELLA EXTRACT
#14PERICYTE HAVING BASIC FIBROBLAST GROWTH FACTOR (BFGF) GENE INTRODUCED THEREIN
#15Ultrathin Interfacial Layer on a Hydrogel to Direct its Surface Properties and Cell Adhesion
#16FULLY FUNCTIONAL CONTRACTILE GASTROINTESTINAL ORGANOID SYSTEM, GENERATED FROM HUMAN-INDUCED PLURIPOTENT STEM CELLS TO DEVELOP A HIGH THROUGHPUT SYSTEM FOR DETECTING EXISTING AND NEWLY-EMERGING PATHOGENS, DRUGS, TOXICITY AND THEREOF
#17METHODS FOR ISOLATING AND CULTURING LIVING CELLS USING METHOD OF PERMEABILIZING CELL MEMBRANE
#18METHODS OF GENERATING PLURIPOTENT STEM CELL-DERIVED VASCULAR SMOOTH MUSCLE CELLS, USES, AND COMPOSITION RELATED THERETO
#19Lineage Reprogramming to Induced Cardiac Progenitor Cells (iCPC) By Defined Factors
#20Tissue engineered synthetic support structure
#21METHODS OF PRECONDITIONING VASCULAR CELLS FOR TRANSDUCTION, METHODS OF TRANSDUCTION AND METHODS OF PRESERVING TRANSDUCED CELLS
#22Methods for obtaining induced smooth muscle cells
#23Generating vasculogenic cell populations
#24BIOMIMETIC PLATFORMS TO MODEL VASCULAR PATHOPHYSIOLOGY, DIAGNOSTICS, AND THERAPY
#25Fluidic systems, devices and methods for inducing anisotropy in polymeric materials
#26Human iPSC-derived vascular-related and hematopoetic cells for therapies and toxicology/drug screenings
#27Human uterine cervical stem cell population and uses thereof
#28MODEL FOR IN-VITRO SIMULATION OF THE BEHAVIOUR OF DYSFUNCTIONAL VESSELS
#29Ultrathin interfacial layer on a hydrogel to direct its surface properties and cell adhesion
#30CPC EXOSOMES MIRNA373 COMBINATION THERAPIES
#31Immortalized sweat gland myoepithelial cell
#32HUMAN PLURIPOTENT STEM CELL-BASED SCREENING FOR SMOOTH MUSCLE CELL DIFFERENTIATION AND DISEASE
#33METHOD FOR DELAYED RECTIFIER CURRENT ENHANCEMENT, CHARACTERIZATION, AND ANALYSIS IN HUMAN INDUCED PLURIPOTENT STEM CELLS
#34Method and apparatus for screening compounds that have preventative and therapeutic activities against endothelial glycocalyx-related diseases
#35Methods and systems for converting precursor cells into intestinal tissues through directed differentiation
#36Methods of producing multi-layered tubular tissue constructs
#37MATERIALS AND METHODS FOR TREATMENT OF MEROSIN-DEFICIENT COGENITAL MUSCULAR DYSTROPHY (MDCMD) AND OTHER LAMININ, ALPHA 2 (LAMA2) GENE RELATED CONDITIONS OR DISORDERS
#38CELL SPHEROIDS CONTAINING CAPILLARY STRUCTURES AND METHODS OF USING SAME
#39Human iPSC-derived vascular-related and hematopoetic cells for therapies and toxicology/drug screenings
#40Myocyte-derived flow assist device: extravasal sheaths of rhythmically contracting myocytes aiding flow of biological fluids
#41HOLLOW CELLULAR MICROFIBRE AND METHOD FOR PRODUCING SUCH A HOLLOW CELLULAR MICROFIBRE
#42OPTIMIZED STRATEGY FOR EXON SKIPPING MODIFICATIONS USING CRISPR/CAS9 WITH TRIPLE GUIDE SEQUENCES
#43METHODS FOR ISOLATING AND CULTURING LIVING CELLS USING METHOD OF PERMEABILIZING CELL MEMBRANE
#44MULTI LAYER SCAFFOLD DESIGN WITH SPACIAL ARRANGEMENT OF CELLS TO MODULATE TISSUE GROWTH
#45ENGINEERING MULTILEVEL CELL SHEET-DERIVED BLOOD VESSELS
#46METHOD FOR DIRECTLY PRODUCING CARDIAC PRECURSOR CELL OR MYOCARDIAL CELL FROM FIBROBLAST
#47Generation of Expandable Cardiovascular Progenitor Cells
#48Human pluripotent stem cell-based screening for smooth muscle cell differentiation and disease
#49POLYMERIC FIBER-SCAFFOLDED ENGINEERED TISSUES AND USES THEREOF
#50MICROVESICLE AND STEM CELL COMPOSITIONS FOR THERAPEUTIC APPLICATIONS
#51Innervation Of Engineered Structures
#52Fluidic systems, devices and methods for inducing anisotropy in polymeric materials
#53Generating vasculogenic cell populations
#54MULTIPOTENT STEM CELLS AND USES THEREOF
#55MULTIPOTENT STEM CELLS AND USES THEREOF
#56Multipotent stem cells and uses thereof
#57Methods and systems for converting precursor cells into intestinal tissues through directed differentiation
#58BK Channels as Non-Genomic Estrogen Targets for Overactive Bladder
#59MULTIPOTENT STEM CELLS AND USES THEREOF
#60Method for producing three-dimensional cell aggregates
#61Methods for immortalization of epithelial cells
#62Cultured cell leaflet material
#63THREE-DIMENSIONAL TISSUE AND PRODUCTION METHOD THEREFOR
#64MULTIPOTENT STEM CELLS AND USES THEREOF
#65Therapeutic method using cardiac tissue-derived pluripotent stem cells
#66Human IPSC-derived vascular-related and hematopoetic cells for therapies and toxicology/drug screenings
#67Compositions for mesoderm derived ISL1+ multipotent cells (IMPs), epicardial progenitor cells (EPCs) and multipotent C56C cells (C56Cs) and methods of producing and using same
#68Myocyte-derived flow assist device: extravasal sheaths of rhythmically contracting myocytes aiding flow of biological fluids
#69Lineage reprogramming to induced cardiac progenitor cells (iCPC) by defined factors
#70Laminous vascular constructs combining cell sheet engineering and electrospinning technologies
#71System and substances for cryopreservation of viable cells
#72Methods of modulating smooth muscle cell proliferation and differentiation
#73Tubular bioengineered smooth muscle structures
#74Innervation of engineered structures
#75Generating vasculogenic cell populations
#76Populations of smooth muscle cells of specific embryonic lineages
#77ROBUST AND EFFICIENT DIFFERENTIATION OF HUMAN PLURIPOTENT STEM CELLS TO MULTIPOTENT VASCULAR PROGENITORS
#78Extracellular matrices which can be used as scaffold for living cells
#79Isolation and characterization of progenitor cells from mesothelium
#80DERIVATION AND MATURATION OF SYNTHETIC AND CONTRACTILE VASCULAR SMOOTH MUSCLE CELLS FROM HUMAN PLURIPOTENT STEM CELLS
#81Methods and systems for converting precursor cells into intestinal tissues through directed differentiation
#82Upregulation of integrin linked kinase (ILK) to provide cardioprotective effects
#83Methods of modulating smooth muscle cell proliferation and differentiation
#84MULTIPOTENT STEM CELLS AND USES THEREOF
#85COMPOSITIONS FOR MESODERM DERIVED ISL1+ MULTIPOTENT CELLS (IMPs), EPICARDIAL PROGENITOR CELLS (EPCs) AND MULTIPOTENT CD56C CELLS (C56Cs) AND METHODS OF PRODUCING AND USING SAME
#86MODULATION OF THE INTEGRIN LINKED KINASE SIGNALING PATHWAY TO PROMOTE CARDIAC CELL PROLIFERATION AND SELF-RENEWAL
#87Method for isolating smooth muscle stem cells
#88METHODS FOR PRODUCTION OF ATRIAL PROGENITORS AND THEIR DIFFERENTIATION INTO SMOOTH MUSCLE CELLS AND CARDIOMYOCYTES
#89MULTIPOTENT STEM CELLS AND USES THEREOF
#90Nestin-expressing hair follicle stem cells
#91Generation, Characterization and Isolation of Neuroepithelial Stem Cells and Lineage Restricted Intermediate Precursor
#92METHOD FOR OBTAINING HUMAN SMOOTH MUSCULAR CELLS AND USES THEREOF
#93Tissue engineering support
#94Modulation of the integrin linked kinase signaling pathway to promote cardiac cell proliferation and self-renewal
#95Method for determining the selectivity of a pre-synaptic neuromuscular blocking substance
#96Transplants for myocardial scars
#97Isolation of mammalian CNS glial-restricted precursor cells
#98Three dimensional bioengineered smooth muscle tissue and sphincters and methods therefor
#99Transplants for myocardial scars
#100Augmentation and repair of age-related soft tissue defects
#101Transplants for myocardial scars